ThermoGenesis Holdings, Inc. Logo

ThermoGenesis Holdings, Inc.

THMO

(1.2)
Stock Price

0,17 USD

-161.65% ROA

-306.16% ROE

-0.06x PER

Market Cap.

1.568.250,00 USD

192.61% DER

0% Yield

-148.16% NPM

ThermoGenesis Holdings, Inc. Stock Analysis

ThermoGenesis Holdings, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

ThermoGenesis Holdings, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.66x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

3 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

4 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

5 ROE

The stock's ROE indicates a negative return (-456.94%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-141.79%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 DER

The company has a high debt to equity ratio (271%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

ThermoGenesis Holdings, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

ThermoGenesis Holdings, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

ThermoGenesis Holdings, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

ThermoGenesis Holdings, Inc. Revenue
Year Revenue Growth
1986 100.000
1987 100.000 0%
1988 500.000 80%
1989 1.200.000 58.33%
1990 1.100.000 -9.09%
1991 1.800.000 38.89%
1992 1.800.000 0%
1993 2.000.000 10%
1994 2.700.000 25.93%
1995 3.300.000 18.18%
1996 4.100.000 19.51%
1997 6.600.000 37.88%
1998 4.400.000 -50%
1999 5.000.000 12%
2000 4.211.000 -18.74%
2001 5.792.000 27.3%
2002 9.549.000 39.34%
2003 10.187.000 6.26%
2004 11.646.000 12.53%
2005 10.177.000 -14.43%
2006 12.048.000 15.53%
2007 16.751.000 28.08%
2008 21.946.000 23.67%
2009 19.799.000 -10.84%
2010 23.088.000 14.25%
2011 23.400.000 1.33%
2012 19.023.000 -23.01%
2013 17.963.000 -5.9%
2014 15.987.000 -12.36%
2015 16.042.000 0.34%
2016 11.929.000 -34.48%
2017 14.525.000 17.87%
2018 9.672.000 -50.18%
2019 13.047.000 25.87%
2020 9.744.000 -33.9%
2021 9.294.000 -4.84%
2022 10.483.000 11.34%
2023 8.776.000 -19.45%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

ThermoGenesis Holdings, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 400.000 100%
1996 1.300.000 69.23%
1997 3.600.000 63.89%
1998 3.900.000 7.69%
1999 2.000.000 -95%
2000 1.624.000 -23.15%
2001 1.782.000 8.87%
2002 2.283.000 21.94%
2003 2.937.000 22.27%
2004 3.472.000 15.41%
2005 5.673.000 38.8%
2006 4.157.000 -36.47%
2007 4.108.000 -1.19%
2008 7.172.000 42.72%
2009 5.222.000 -37.34%
2010 5.013.000 -4.17%
2011 3.003.000 -66.93%
2012 3.729.000 19.47%
2013 2.991.000 -24.67%
2014 3.468.000 13.75%
2015 5.939.000 41.61%
2016 3.230.000 -83.87%
2017 2.497.000 -29.36%
2018 3.012.000 17.1%
2019 2.396.000 -25.71%
2020 2.477.000 3.27%
2021 2.209.000 -12.13%
2022 1.659.000 -33.15%
2023 1.064.000 -55.92%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

ThermoGenesis Holdings, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 1.600.000 100%
1997 3.500.000 54.29%
1998 4.600.000 23.91%
1999 4.800.000 4.17%
2000 4.195.000 -14.42%
2001 3.889.000 -7.87%
2002 4.843.000 19.7%
2003 5.014.000 3.41%
2004 5.174.000 3.09%
2005 5.837.000 11.36%
2006 7.156.000 18.43%
2007 9.630.000 25.69%
2008 10.165.000 5.26%
2009 9.249.000 -9.9%
2010 7.686.000 -20.34%
2011 8.669.000 11.34%
2012 7.983.000 -8.59%
2013 5.645.000 -41.42%
2014 8.490.000 33.51%
2015 10.695.000 20.62%
2016 8.231.000 -29.94%
2017 11.051.000 25.52%
2018 8.286.000 -33.37%
2019 6.377.000 -29.94%
2020 5.729.000 -11.31%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

ThermoGenesis Holdings, Inc. EBITDA
Year EBITDA Growth
1986 -600.000
1987 -600.000 0%
1988 -1.000.000 40%
1989 -400.000 -150%
1990 -400.000 0%
1991 -100.000 -300%
1992 -1.300.000 92.31%
1993 -300.000 -333.33%
1994 -500.000 40%
1995 -400.000 -25%
1996 -400.000 0%
1997 -4.500.000 91.11%
1998 -9.100.000 50.55%
1999 -5.500.000 -65.45%
2000 -5.177.000 -6.24%
2001 -4.406.000 -17.5%
2002 -4.701.000 6.28%
2003 -5.398.000 12.91%
2004 -4.542.000 -18.85%
2005 -8.055.000 43.61%
2006 -6.853.000 -17.54%
2007 -7.992.000 14.25%
2008 -9.824.000 18.65%
2009 -8.304.000 -18.3%
2010 -4.762.000 -74.38%
2011 -2.369.000 -101.01%
2012 -4.775.000 50.39%
2013 -6.849.000 30.28%
2014 -8.047.000 14.89%
2015 -13.508.000 40.43%
2016 -10.865.000 -24.33%
2017 -9.240.000 -17.59%
2018 -10.488.000 11.9%
2019 -3.976.000 -163.78%
2020 -8.903.000 55.34%
2021 -5.796.000 -53.61%
2022 -6.196.000 6.46%
2023 -6.140.000 -0.91%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

ThermoGenesis Holdings, Inc. Gross Profit
Year Gross Profit Growth
1986 100.000
1987 100.000 0%
1988 400.000 75%
1989 700.000 42.86%
1990 700.000 0%
1991 1.200.000 41.67%
1992 600.000 -100%
1993 1.000.000 40%
1994 1.300.000 23.08%
1995 1.400.000 7.14%
1996 2.500.000 44%
1997 2.600.000 3.85%
1998 -600.000 533.33%
1999 1.300.000 146.15%
2000 642.000 -102.49%
2001 780.000 17.69%
2002 1.991.000 60.82%
2003 2.287.000 12.94%
2004 3.802.000 39.85%
2005 3.088.000 -23.12%
2006 4.343.000 28.9%
2007 5.197.000 16.43%
2008 6.970.000 25.44%
2009 5.693.000 -22.43%
2010 7.445.000 23.53%
2011 8.837.000 15.75%
2012 6.333.000 -39.54%
2013 6.365.000 0.5%
2014 5.886.000 -8.14%
2015 4.749.000 -23.94%
2016 2.744.000 -73.07%
2017 5.839.000 53.01%
2018 2.193.000 -166.26%
2019 5.696.000 61.5%
2020 1.259.000 -352.42%
2021 3.493.000 63.96%
2022 2.710.000 -28.89%
2023 1.580.000 -71.52%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

ThermoGenesis Holdings, Inc. Net Profit
Year Net Profit Growth
1986 -800.000
1987 -800.000 0%
1988 -1.100.000 27.27%
1989 -500.000 -120%
1990 -800.000 37.5%
1991 -700.000 -14.29%
1992 -1.500.000 53.33%
1993 -300.000 -400%
1994 0 0%
1995 -100.000 100%
1996 -600.000 83.33%
1997 -4.800.000 87.5%
1998 -9.600.000 50%
1999 -6.100.000 -57.38%
2000 -5.818.000 -4.85%
2001 -6.153.000 5.44%
2002 -5.038.000 -22.13%
2003 -5.603.000 10.08%
2004 -4.777.000 -17.29%
2005 -8.220.000 41.89%
2006 -6.142.000 -33.83%
2007 -6.776.000 9.36%
2008 -9.181.000 26.2%
2009 -8.550.000 -7.38%
2010 -5.193.000 -64.64%
2011 -2.567.000 -102.3%
2012 -4.986.000 48.52%
2013 -3.086.000 -61.57%
2014 -8.631.000 64.25%
2015 -14.852.000 41.89%
2016 -18.588.000 20.1%
2017 -29.095.000 36.11%
2018 -39.716.000 26.74%
2019 -13.928.000 -185.15%
2020 -23.509.000 40.75%
2021 -18.284.000 -28.58%
2022 -11.270.000 -62.24%
2023 -14.460.000 22.06%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

ThermoGenesis Holdings, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1986 -6.667
1987 -6.667 0%
1988 -8.271 19.4%
1989 -3.731 -121.66%
1990 -4.651 19.78%
1991 -3.196 -45.53%
1992 -6.073 47.36%
1993 -1.167 -420.31%
1994 0 0%
1995 -283 100%
1996 -1.700 83.34%
1997 -10.909 84.43%
1998 -18.286 40.34%
1999 -10.664 -71.46%
2000 -8.444 -26.29%
2001 -6.968 -21.18%
2002 -5.151 -35.27%
2003 -5.515 6.58%
2004 -4.118 -33.9%
2005 -6.519 36.82%
2006 -4.460 -46.14%
2007 -4.423 -0.86%
2008 -5.931 25.43%
2009 -5.495 -7.94%
2010 -3.333 -64.84%
2011 -1.560 -113.79%
2012 -2.738 43.06%
2013 -1.681 -62.98%
2014 -3.206 47.6%
2015 -3.313 3.2%
2016 -2.778 -19.22%
2017 -712 -290.72%
2018 -971 26.78%
2019 -222 -339.37%
2020 -168 -32.34%
2021 -70 -142.03%
2022 -20 -245%
2023 -6 -300%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

ThermoGenesis Holdings, Inc. Free Cashflow
Year Free Cashflow Growth
1987 0
1988 0 0%
1989 0 0%
1990 0 0%
1991 -300.000 100%
1992 -1.200.000 75%
1993 -700.000 -71.43%
1994 100.000 800%
1995 0 0%
1996 -1.900.000 100%
1997 -5.600.000 66.07%
1998 -8.400.000 33.33%
1999 -6.600.000 -27.27%
2000 -4.457.000 -48.08%
2001 -4.529.000 1.59%
2002 -5.634.000 19.61%
2003 -5.805.000 2.95%
2004 -5.327.000 -8.97%
2005 -8.163.000 34.74%
2006 -3.563.000 -129.1%
2007 -8.383.000 57.5%
2008 -8.965.000 6.49%
2009 -9.804.000 8.56%
2010 -4.898.000 -100.16%
2011 -2.358.000 -107.72%
2012 -4.430.000 46.77%
2013 -3.473.000 -27.56%
2014 -8.238.000 57.84%
2015 -11.236.000 26.68%
2016 -10.335.000 -8.72%
2017 -7.590.000 -36.17%
2018 -8.221.000 7.68%
2019 -3.442.000 -138.84%
2020 -14.416.000 76.12%
2021 -6.713.000 -114.75%
2022 -7.683.000 12.63%
2023 -431.000 -1682.6%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

ThermoGenesis Holdings, Inc. Operating Cashflow
Year Operating Cashflow Growth
1987 0
1988 0 0%
1989 0 0%
1990 0 0%
1991 -200.000 100%
1992 -1.200.000 83.33%
1993 -700.000 -71.43%
1994 100.000 800%
1995 100.000 0%
1996 -1.700.000 105.88%
1997 -4.700.000 63.83%
1998 -8.000.000 41.25%
1999 -6.500.000 -23.08%
2000 -4.312.000 -50.74%
2001 -4.294.000 -0.42%
2002 -5.459.000 21.34%
2003 -5.713.000 4.45%
2004 -4.478.000 -27.58%
2005 -7.931.000 43.54%
2006 -2.998.000 -164.54%
2007 -7.762.000 61.38%
2008 -8.451.000 8.15%
2009 -8.757.000 3.49%
2010 -4.428.000 -97.76%
2011 -2.092.000 -111.66%
2012 -3.885.000 46.15%
2013 -3.082.000 -26.05%
2014 -7.836.000 60.67%
2015 -10.649.000 26.42%
2016 -9.625.000 -10.64%
2017 -7.215.000 -33.4%
2018 -6.983.000 -3.32%
2019 -3.260.000 -114.2%
2020 -14.393.000 77.35%
2021 -6.620.000 -117.42%
2022 -7.283.000 9.1%
2023 -251.000 -2801.59%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

ThermoGenesis Holdings, Inc. Capital Expenditure
Year Capital Expenditure Growth
1987 0
1988 0 0%
1989 0 0%
1990 0 0%
1991 100.000 100%
1992 0 0%
1993 0 0%
1994 0 0%
1995 100.000 100%
1996 200.000 50%
1997 900.000 77.78%
1998 400.000 -125%
1999 100.000 -300%
2000 145.000 31.03%
2001 235.000 38.3%
2002 175.000 -34.29%
2003 92.000 -90.22%
2004 849.000 89.16%
2005 232.000 -265.95%
2006 565.000 58.94%
2007 621.000 9.02%
2008 514.000 -20.82%
2009 1.047.000 50.91%
2010 470.000 -122.77%
2011 266.000 -76.69%
2012 545.000 51.19%
2013 391.000 -39.39%
2014 402.000 2.74%
2015 587.000 31.52%
2016 710.000 17.32%
2017 375.000 -89.33%
2018 1.238.000 69.71%
2019 182.000 -580.22%
2020 23.000 -691.3%
2021 93.000 75.27%
2022 400.000 76.75%
2023 180.000 -122.22%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

ThermoGenesis Holdings, Inc. Equity
Year Equity Growth
1986 1.900.000
1987 1.900.000 0%
1988 1.000.000 -90%
1989 600.000 -66.67%
1990 500.000 -20%
1991 1.400.000 64.29%
1992 1.600.000 12.5%
1993 2.000.000 20%
1994 2.100.000 4.76%
1995 2.000.000 -5%
1996 4.400.000 54.55%
1997 8.000.000 45%
1998 5.600.000 -42.86%
1999 6.700.000 16.42%
2000 5.692.000 -17.71%
2001 7.932.000 28.24%
2002 10.193.000 22.18%
2003 10.574.000 3.6%
2004 20.968.000 49.57%
2005 14.031.000 -49.44%
2006 41.972.000 66.57%
2007 37.812.000 -11%
2008 30.525.000 -23.87%
2009 22.454.000 -35.94%
2010 17.779.000 -26.3%
2011 20.093.000 11.52%
2012 15.898.000 -26.39%
2013 13.318.000 -19.37%
2014 48.698.000 72.65%
2015 34.902.000 -39.53%
2016 32.273.000 -8.15%
2017 33.699.000 4.23%
2018 8.442.000 -299.18%
2019 386.000 -2087.05%
2020 5.800.000 93.34%
2021 3.828.000 -51.52%
2022 4.296.000 10.89%
2023 3.000.000 -43.2%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

ThermoGenesis Holdings, Inc. Assets
Year Assets Growth
1986 2.200.000
1987 2.200.000 0%
1988 1.300.000 -69.23%
1989 1.100.000 -18.18%
1990 1.900.000 42.11%
1991 1.900.000 0%
1992 2.200.000 13.64%
1993 2.300.000 4.35%
1994 2.500.000 8%
1995 2.700.000 7.41%
1996 5.900.000 54.24%
1997 10.200.000 42.16%
1998 7.800.000 -30.77%
1999 8.100.000 3.7%
2000 6.735.000 -20.27%
2001 9.553.000 29.5%
2002 12.239.000 21.95%
2003 12.791.000 4.32%
2004 24.114.000 46.96%
2005 17.466.000 -38.06%
2006 47.603.000 63.31%
2007 43.790.000 -8.71%
2008 38.282.000 -14.39%
2009 27.655.000 -38.43%
2010 24.030.000 -15.09%
2011 24.399.000 1.51%
2012 21.080.000 -15.74%
2013 18.529.000 -13.77%
2014 62.888.000 70.54%
2015 50.757.000 -23.9%
2016 49.899.000 -1.72%
2017 51.111.000 2.37%
2018 14.611.000 -249.81%
2019 15.214.000 3.96%
2020 20.860.000 27.07%
2021 20.652.000 -1.01%
2022 19.386.000 -6.53%
2023 15.921.000 -21.76%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

ThermoGenesis Holdings, Inc. Liabilities
Year Liabilities Growth
1986 300.000
1987 300.000 0%
1988 300.000 0%
1989 500.000 40%
1990 1.400.000 64.29%
1991 500.000 -180%
1992 600.000 16.67%
1993 300.000 -100%
1994 400.000 25%
1995 700.000 42.86%
1996 1.500.000 53.33%
1997 2.200.000 31.82%
1998 2.200.000 0%
1999 1.400.000 -57.14%
2000 1.043.000 -34.23%
2001 1.621.000 35.66%
2002 2.046.000 20.77%
2003 2.217.000 7.71%
2004 3.146.000 29.53%
2005 3.435.000 8.41%
2006 5.631.000 39%
2007 5.978.000 5.8%
2008 7.757.000 22.93%
2009 5.201.000 -49.14%
2010 6.251.000 16.8%
2011 4.306.000 -45.17%
2012 5.182.000 16.9%
2013 5.211.000 0.56%
2014 14.190.000 63.28%
2015 15.855.000 10.5%
2016 17.626.000 10.05%
2017 17.899.000 1.53%
2018 7.880.000 -127.14%
2019 14.298.000 44.89%
2020 14.990.000 4.62%
2021 17.255.000 13.13%
2022 16.063.000 -7.42%
2023 12.658.000 -26.9%

ThermoGenesis Holdings, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
3.88
Net Income per Share
-8.96
Price to Earning Ratio
-0.06x
Price To Sales Ratio
0.16x
POCF Ratio
-0.44
PFCF Ratio
-0.35
Price to Book Ratio
0.29
EV to Sales
0.61
EV Over EBITDA
-1.11
EV to Operating CashFlow
-2.06
EV to FreeCashFlow
-1.31
Earnings Yield
-17.92
FreeCashFlow Yield
-2.86
Market Cap
0,00 Bil.
Enterprise Value
0,01 Bil.
Graham Number
18.68
Graham NetNet
-2.98

Income Statement Metrics

Net Income per Share
-8.96
Income Quality
0.19
ROE
-4.84
Return On Assets
-0.9
Return On Capital Employed
-0.83
Net Income per EBT
0.97
EBT Per Ebit
2.54
Ebit per Revenue
-0.6
Effective Tax Rate
-0.51

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.13
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.24
Operating Profit Margin
-0.6
Pretax Profit Margin
-1.53
Net Profit Margin
-1.48

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-1.14
Free CashFlow per Share
-1.79
Capex to Operating CashFlow
0.57
Capex to Revenue
-0.17
Capex to Depreciation
-1.52
Return on Invested Capital
-0.61
Return on Tangible Assets
-1.62
Days Sales Outstanding
13.83
Days Payables Outstanding
29.34
Days of Inventory on Hand
90.41
Receivables Turnover
26.4
Payables Turnover
12.44
Inventory Turnover
4.04
Capex per Share
-0.65

Balance Sheet

Cash per Share
1,60
Book Value per Share
1,73
Tangible Book Value per Share
0.49
Shareholders Equity per Share
1.73
Interest Debt per Share
6.82
Debt to Equity
1.93
Debt to Assets
0.52
Net Debt to EBITDA
-0.82
Current Ratio
0.78
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
1.93
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.13
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
2238500
Debt to Market Cap
5.32

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

ThermoGenesis Holdings, Inc. Dividends
Year Dividends Growth

ThermoGenesis Holdings, Inc. Profile

About ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

CEO
Dr. Xiaochun Xu M.B.A., Ph.D.
Employee
40
Address
2711 Citrus Road
Rancho Cordova, 95742

ThermoGenesis Holdings, Inc. Executives & BODs

ThermoGenesis Holdings, Inc. Executives & BODs
# Name Age
1 Mr. Jeffery Cauble CPA
Chief Financial Officer & Corporate Secretary
70
2 Dr. Xiaochun Xu M.B.A., Ph.D.
Chairman of the Board & Chief Executive Officer
70

ThermoGenesis Holdings, Inc. Competitors